12:00 AM
Oct 07, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Fate Therapeutics completes IPO

Fate Therapeutics Inc. (NASDAQ:FATE), San Diego, Calif.
Business: Gene/Cell therapy, Cancer, Musculoskeletal
Date completed: 10/1/13

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >